Reuben Antony, M.D.
Associate Professor, Division of Clinical Pediatrics
To see if Reuben Antony is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Department
Locations and Contact
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Phone: 916-734-5959
Additional Numbers
Clinic Phone
Clinic Fax
Physician Referrals
Philosophy of Care
In the last decade we have gained many new and exciting insights into the mechanistic basis of childhood CNS malignancies. Everyday I aim to provide compassionate and cutting edge care to the children and families who have placed their trust in us.
Clinical Interests
Dr. Antony offers care to children with tumors of the Central Nervous System and to children with Cancer Predisposition Syndromes.
Research/Academic Interests
Dr. Antony's research and academic interest is drug development in Neuro-oncology and Neurofibromatosis Type 1.
Division
Pediatric Hematology/Oncology
Center/Program Affiliation
Medical School
M.B.B.S., St. Johns Medical College, Bangalore, India 1996
Residency
Pediatrics, New York Medical College, New York NY 2006-2008
Fellowship
Pediatric Hematology and Oncology, Children's Hospital of Los Angeles, Los Angeles CA 2008-2011
Fellowship
Pediatric Hematology and Oncology, Great Ormond Street Hospital for Sick Children, London, UK 2001-2003
Fellowship
Pediatric Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada 2005-2006
Pediatric Subspecialty Teaching Award Nominee (one of five nominated pediatricians), 2016
Outstanding Pediatric Faculty (Clinical, Academic, Research) nominee (one of five nominated), 2015
Pediatric Subspecialty Teaching Award Nominee (one of five nominated pediatricians), 2015
Best Teacher Award (Dept. of Pediatrics), University of Illinois College of Medicine (UICOMP), 2014
Partap S, Plant A, Pruthi S, Reynolds R, Ruggieri P, Stearns D, Storm P, Wang A, Warren K, Whipple N, Zaky W, McMillian NR, Pluchino LA. Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Dec;20(12):1339-1362. doi:10.6004/jnccn.2022.0062. PMID:36509072.
Khan S, Solano-Paez P, Suwal T, Lu M, Al-Karmi S, Ho B, Mumal I, Shago M, Hoffman LM, Dodgshun A, Nobusawa S, Tabori U, Bartels U, Ziegler DS, Hansford JR, Ramaswamy V, Hawkins C, Dufour C, André N, Bouffet E, Huang A; Rare Brain Tumor Registry. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study. Lancet Child Adolesc Health. 2021 Nov;5(11):800-813. doi:10.1016/S2352-4642(21)00245-5. Epub 2021 Sep 30. PMID:34599879.
Speckhart BA, Bugaieski E, Antony R, Fernandez KS. Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma. Pediatr Blood Cancer. 2020 Jul;67(7):e28259. doi:10.1002/pbc.28259. Epub 2020 May 13. PMID:32400949.
Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, Van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, Metrock LK, Jin LW, Antony R, Alashari M, Cheshier S, Whipple NS, Bruggers C, Raffel C, Gupta N, Kline CN, Reddy A, Banerjee A, Hall MD, Mehta MP, Khatib Z, Maher OM, Brathwaite C, Pekmezci M, Phillips JJ, Bollen AW, Tihan T, Lucas JT Jr, Broniscer A, Berger MS, Perry A, Orr BA, Solomon DA. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol. 2020 Jun;139(6):1071-1088. doi:10.1007/s00401-020-02155-5. Epub 2020 Apr 17. PMID:32303840.
Goodarzi A, Garza N, Lechpammer M, Anthony R, Zwienenberg M. The molecular oncology of bilateral high-grade thalamic astrocytomas in children. Childs Nerv Syst. 2019 Nov;35(11):2047-2054. doi:10.1007/s00381-019-04372-0. Epub 2019 Sep 14. PMID:31522255.
Fernández KS, Antony R, Kumar A. Patients with "ALPS-like phenotype" diagnosed with immune dysregulation due to LRBA deficiency. Pediatr Blood Cancer. 2019 Mar;66(3):e27558. doi:10.1002/pbc.27558. Epub 2018 Nov 26. PMID:30479033.
Fernández KS, Antony R. Overview of Malignant Solid Tumors: Neonates. Int J Pediatr Neonat Care. 2019;4:147. doi:10.15344/2455-2364/2019/147.
McCarthy LC, Fernandez KS, Antony R. Challenges in the Diagnosis and Management of Pediatric Hemophagocytic Lymphohistiocytosis. Clin Pediatr (Phila). 2018 Aug;57(9):1107-1113. doi:10.1177/0009922817735997. Epub 2017 Oct 24. PMID:29064275.